FDA finds contamination concerns at Ameridose

November 12, 2012

(AP)—Federal health inspectors have found more than a dozen sterility problems, including insects, at a drugmaking facility with the same founders as the specialty pharmacy linked to a deadly meningitis outbreak.

The has released the results of a monthlong inspection of Ameridose, a Westborough, Mass.-based company that makes a variety of injectable drugs.

Inspectors say they found insects within 10 feet of a supposedly sterile area where drugs are manufactured. In another case, inspectors reported a bird flying into a room where drugs are stored.

Ameridose agreed to shut down for inspection in October after tainted steroids from its sister company, the New England Compounding Center, were linked to a fungal that's spread to 19 states and caused 32 deaths.

Explore further: 2nd firm agrees to temporary shutdown in outbreak


Related Stories

2nd firm agrees to temporary shutdown in outbreak

October 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

Suit: Firm provided tainted meds in 2002, man died

October 11, 2012

The compounding pharmacy suspected in a deadly meningitis outbreak settled a lawsuit alleging it produced a tainted shot that caused a man's death in 2004, while a pharmaceutical firm with common owners was accused this summer ...

Steroid pharmacy passed 2011 inspection in Mass.

October 23, 2012

(AP)—The Massachusetts pharmacy linked to a meningitis outbreak that has claimed 23 lives around the country was cleared by state regulators following an inspection last year.

Mass. shuts down another compounding pharmacy

October 29, 2012

(AP)—Massachusetts officials say they have shut down a compounding pharmacy after a surprise inspection prompted by the nationwide meningitis outbreak linked to a different state company.

FDA: Ameridose issues voluntary recall of all products

November 2, 2012

(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release ...

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.